Early BCG vaccine to low-birth-weight infants and the effects on growth in the first year of life: a randomised controlled trial.

BMC Pediatr · 2015 · PMC4587923 · PMID 26416147

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

A combined analysis of these trials showed that early BCG was associated with a borderline significant reduction in infant mortality of 21 % (95 % CI:-2 %; 39 %), and a 48 % (95 % CI: 18 %; 67 %) reduction in neonatal mortality, before most children in the control group received BCG [ 10 ].

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.